These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 11895493)

  • 21. Down-regulation of aquaporin-1 in intrahepatic cholangiocarcinoma is related to tumor progression and mucin expression.
    Aishima S; Kuroda Y; Nishihara Y; Taguchi K; Iguchi T; Taketomi A; Maehara Y; Tsuneyoshi M
    Hum Pathol; 2007 Dec; 38(12):1819-25. PubMed ID: 17854859
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A comprehensive analysis of immunohistochemical studies in intrahepatic cholangiocarcinoma using the survival tree model.
    Iguchi T; Yamashita N; Aishima S; Kuroda Y; Terashi T; Sugimachi K; Taguchi K; Taketomi A; Maehara Y; Tsuneyoshi M
    Oncology; 2009; 76(4):293-300. PubMed ID: 19262069
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Different roles of inducible nitric oxide synthase and cyclooxygenase-2 in carcinogenesis and metastasis of intrahepatic cholangiocarcinoma.
    Aishima S; Mano Y; Tanaka Y; Kubo Y; Shirabe K; Maehara Y; Oda Y
    Hum Pathol; 2013 Jun; 44(6):1031-7. PubMed ID: 23260331
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression and prognostic value of soluble CD97 and its ligand CD55 in intrahepatic cholangiocarcinoma.
    Meng ZW; Liu MC; Hong HJ; Du Q; Chen YL
    Tumour Biol; 2017 Mar; 39(3):1010428317694319. PubMed ID: 28345461
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Activation of c-Src gene product in hepatocellular carcinoma is highly correlated with the indices of early stage phenotype.
    Ito Y; Kawakatsu H; Takeda T; Sakon M; Nagano H; Sakai T; Miyoshi E; Noda K; Tsujimoto M; Wakasa K; Monden M; Matsuura N
    J Hepatol; 2001 Jul; 35(1):68-73. PubMed ID: 11495044
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression of VEGFR-3 in intrahepatic cholangiocarcinoma correlates with unfavorable prognosis through lymphangiogenesis.
    Sha M; Jeong S; Chen XS; Tong Y; Cao J; Sun HY; Xia L; Xu N; Wang X; Han LZ; Xi ZF; Zhang JJ; Kong XN; Xia Q
    Int J Biol Sci; 2018; 14(10):1333-1342. PubMed ID: 30123080
    [No Abstract]   [Full Text] [Related]  

  • 27. Immunohistochemically demonstrated lymph node micrometastasis and prognosis in patients with otherwise node-negative hilar cholangiocarcinoma.
    Tojima Y; Nagino M; Ebata T; Uesaka K; Kamiya J; Nimura Y
    Ann Surg; 2003 Feb; 237(2):201-7. PubMed ID: 12560778
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The expression of matrix metalloproteinases in intrahepatic cholangiocarcinoma, hilar (Klatskin tumor), middle and distal extrahepatic cholangiocarcinoma, gallbladder cancer, and ampullary carcinoma: role of matrix metalloproteinases in tumor progression and prognosis.
    Kirimlioğlu H; Türkmen I; Başsüllü N; Dirican A; Karadağ N; Kirimlioğlu V
    Turk J Gastroenterol; 2009 Mar; 20(1):41-7. PubMed ID: 19330734
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Analysis of microsatellite instability, K-ras gene mutation and p53 protein overexpression in intrahepatic cholangiocarcinoma.
    Isa T; Tomita S; Nakachi A; Miyazato H; Shimoji H; Kusano T; Muto Y; Furukawa M
    Hepatogastroenterology; 2002; 49(45):604-8. PubMed ID: 12063950
    [TBL] [Abstract][Full Text] [Related]  

  • 30. C-Met overexpression in node-positive breast cancer identifies patients with poor clinical outcome independent of Her2/neu.
    Lengyel E; Prechtel D; Resau JH; Gauger K; Welk A; Lindemann K; Salanti G; Richter T; Knudsen B; Vande Woude GF; Harbeck N
    Int J Cancer; 2005 Feb; 113(4):678-82. PubMed ID: 15455388
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic Risk Factors Associated with Recurrence and Metastasis After Radical Resection in Patients with Hepatolithiasis Complicated by Intrahepatic Cholangiocarcinoma.
    Zhu Y; Zhu Y; Cai F; Zhao J; Liu F
    Cell Biochem Biophys; 2015 Nov; 73(2):455-460. PubMed ID: 27352338
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cytokeratin profile relates to histological subtypes and intrahepatic location of intrahepatic cholangiocarcinoma and primary sites of metastatic adenocarcinoma of liver.
    Shimonishi T; Miyazaki K; Nakanuma Y
    Histopathology; 2000 Jul; 37(1):55-63. PubMed ID: 10931219
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinicopathological Significance of Osteopontin in Cholangiocarcinoma Cases.
    Laohaviroj M; Chamgramol Y; Pairojkul C; Mulvenna J; Sripa B
    Asian Pac J Cancer Prev; 2016; 17(1):201-5. PubMed ID: 26838210
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression of c-erbB-2 proto-oncogene in extrahepatic cholangiocarcinoma and its clinical significance.
    Zheng J; Zhu YM
    Hepatobiliary Pancreat Dis Int; 2007 Aug; 6(4):412-5. PubMed ID: 17690040
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Decreased roundabout 1 expression promotes development of intrahepatic cholangiocarcinoma.
    Mano Y; Aishima S; Fukuhara T; Tanaka Y; Kubo Y; Motomura T; Toshima T; Iguchi T; Shirabe K; Maehara Y; Oda Y
    Hum Pathol; 2013 Nov; 44(11):2419-26. PubMed ID: 23953227
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CD24 expression is a prognostic factor in intrahepatic cholangiocarcinoma.
    Su MC; Hsu C; Kao HL; Jeng YM
    Cancer Lett; 2006 Apr; 235(1):34-9. PubMed ID: 16125303
    [TBL] [Abstract][Full Text] [Related]  

  • 37. ZEB1 expression is associated with prognosis of intrahepatic cholangiocarcinoma.
    Terashita K; Chuma M; Hatanaka Y; Hatanaka K; Mitsuhashi T; Yokoo H; Ohmura T; Ishizu H; Muraoka S; Nagasaka A; Tsuji T; Yamamoto Y; Kurauchi N; Shimoyama N; Toyoda H; Kumada T; Kaneoka Y; Maeda A; Ogawa K; Natsuizaka M; Kamachi H; Kakisaka T; Kamiyama T; Taketomi A; Matsuno Y; Sakamoto N
    J Clin Pathol; 2016 Jul; 69(7):593-9. PubMed ID: 26670746
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of resection and transarterial chemoembolisation in the treatment of advanced intrahepatic cholangiocarcinoma--a single-center experience.
    Scheuermann U; Kaths JM; Heise M; Pitton MB; Weinmann A; Hoppe-Lotichius M; Otto G
    Eur J Surg Oncol; 2013 Jun; 39(6):593-600. PubMed ID: 23611755
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lymph node metastasis in intrahepatic cholangiocarcinoma.
    Yamamoto M; Takasaki K; Yoshikawa T
    Jpn J Clin Oncol; 1999 Mar; 29(3):147-50. PubMed ID: 10225697
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reconsideration of the lymph node metastasis pattern (N factor) from intrahepatic cholangiocarcinoma using the International Union Against Cancer TNM staging system for primary liver carcinoma.
    Nozaki Y; Yamamoto M; Ikai I; Yamamoto Y; Ozaki N; Fujii H; Nagahori K; Matsumoto Y; Yamaoka Y
    Cancer; 1998 Nov; 83(9):1923-9. PubMed ID: 9806650
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.